Skip to content

Augmented Reality Mobile Application for Glaucoma Education in the South Bronx

Augmented Reality Mobile Application for Glaucoma Education in the South Bronx

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04421859
Enrollment
50
Registered
2020-06-09
Start date
2020-01-01
Completion date
2022-06-30
Last updated
2022-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

A team at the National Healthcare Group Eye Institute in Singapore have developed an augmented reality mobile phone application, EyeCU, to simulate glaucoma progression and enhance understanding about the disease and its course. It is a bilingual (English/Spanish) application that is free-to-download on the Android and Apple app store. As eye care physicians in the South Bronx, the investigators are hopeful that the findings in this study can be extrapolated to our patients in the South Bronx, where poor health literacy, non-adherence to glaucoma medication and poor follow-up remains a large barrier. The investigators hope that by offering the simulation in both English and Spanish, the investigators will not only be able to improve our patients' understanding of glaucoma, but also improve glaucoma treatment adherence and assess our patient population's responsiveness to augmented reality as an educational platform.

Detailed description

Experimental design: Pilot cohort study Data collection: Patient characteristics such as age, sex, ethnicity, preferred language, zip code, employment status, highest educational attainment, current topical eye medications, Past Ocular History, Past Medical History Recruitment for participation in the study will be performed during glaucoma clinic registration Consent will be conducted by a member of the research team who is not directly involved in the participant's clinical care Pre-intervention glaucoma knowledge questionnaire (NEHEP glaucoma knowledge questionnaire) will be given to participants, to be completed on dedicated clinic tablet device. Post-intervention glaucoma knowledge questionnaire (NEHEP glaucoma knowledge questionnaire) will be given to participants, to be completed on dedicated clinic tablet device. Rate of missed glaucoma follow-up appointments before and 6 months after application use will be collected from the electronic medical record. Rate of medication adherence before and 6 months after application use will be collected from the electronic medical record.

Interventions

OTHEREyeCU Mobile Application

Augmented reality glaucoma education mobile phone application

Sponsors

EyeCU Group
CollaboratorUNKNOWN
VISRE
CollaboratorUNKNOWN
Bronx-Lebanon Hospital Center Health Care System
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\- Patients with a clinical diagnosis of glaucoma on medical therapy for at least 4 months

Exclusion criteria

* Patients with optic neuropathies unrelated to glaucoma * Patients with VA 20/100 or worse in both eyes * Visual defects involving fixation in both eyes * Patients with symptoms impairing ability to operate a smartphone during visit including diplopia, motor difficulties, cognitive impairment, illiteracy * Patients who are unable to read or understand English or Spanish

Design outcomes

Primary

MeasureTime frameDescription
Change in Medication AdherenceBefore and 6 months after interventionSelf-reported adherence to glaucoma medications will be collected from electronic medical record
Change in Questionnaire ScoresFrom date of intervention to date of post-intervention NEHEP glaucoma knowledge test, assessed up to 2 monthsScores of pre- and post-intervention NEHEP glaucoma knowledge questionnaires will be compared
Change in Follow Up AdherenceBefore and 6 months after interventionAttendance rate at glaucoma follow-ups will be collected from electronic medical record

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026